Date Filed | Type | Description |
01/05/2023 |
3
| Eastling Thomas Wilson (Director) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
01/05/2023 |
3
| GNI Group Ltd. (10% Owner) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
01/05/2023 |
3
| Luo Ying (Director) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
08/10/2022 |
4
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.47, valued at
$1.5k
|
|
08/10/2022 |
4
| Miller Seline E. (SVP Finance; Interim CFO & PAO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.47, valued at
$1.5k
|
|
08/10/2022 |
4
| Blouse Grant E. (Chief Scientific Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.47, valued at
$1.5k
|
|
02/23/2022 |
4
| Miller Seline E. (SVP Finance; Interim CFO & PAO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 107,500 options to buy
@ $0.52, valued at
$55.9k
|
|
02/23/2022 |
4
| Blouse Grant E. (Chief Scientific Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 200,000 options to buy
@ $0.52, valued at
$104k
|
|
02/16/2022 |
4
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.46, valued at
$1.5k
|
|
02/16/2022 |
4
| Miller Seline E. (SVP Finance; Interim CFO & PAO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.46, valued at
$1.5k
|
|
02/16/2022 |
4
| Blouse Grant E. (Chief Scientific Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 3,250 shares
@ $0.46, valued at
$1.5k
|
|
01/07/2022 |
4
| Williams Eddie (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 12,308 shares
@ $0 |
|
01/07/2022 |
4
| Ling Geoffrey M.D. (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 12,855 shares
@ $0 |
|
01/07/2022 |
4
| Hunt Andrea (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 7,521 shares
@ $0 |
|
10/21/2021 |
3
| Miller Seline E. (SVP Finance; Interim CFO & PAO) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
10/05/2021 |
4
| Williams Eddie (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 2,980 shares
@ $0 |
|
10/05/2021 |
4
| Ling Geoffrey M.D. (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 2,858 shares
@ $0 |
|
10/05/2021 |
4
| LAWLOR AUGUSTINE (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 5,839 shares
@ $0 |
|
10/05/2021 |
4
| Hunt Andrea (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 1,824 shares
@ $0 |
|
10/05/2021 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 3,588 shares
@ $0 |
|
09/13/2021 |
4
| JEW JEANNE Y (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 28,000 options to buy
@ $4.38, valued at
$122.6k
|
|
09/13/2021 |
3
| JEW JEANNE Y (Director) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
08/11/2021 |
4
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 867 shares
@ $3.62, valued at
$3.1k
|
|
08/11/2021 |
4
| Levy Howard (Chief Medical Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 639 shares
@ $3.62, valued at
$2.3k
|
|
08/11/2021 |
4
| Blouse Grant E. (Chief Scientific Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Bought 1,163 shares
@ $3.62, valued at
$4.2k
|
|
07/15/2021 |
3
| Blouse Grant E. (Chief Scientific Officer) has filed a Form 3 on CATALYST BIOSCIENCES, INC. |
07/02/2021 |
4
| Williams Eddie (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 1,414 shares
@ $0 Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
07/02/2021 |
4
| TETLOW SHARON (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
07/02/2021 |
4
| Ling Geoffrey M.D. (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 2,713 shares
@ $0 Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
07/02/2021 |
4
| LAWLOR AUGUSTINE (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 5,542 shares
@ $0 Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
07/02/2021 |
4
| Hunt Andrea (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 2,886 shares
@ $0 Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
07/02/2021 |
4
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 3,406 shares
@ $0 Granted 14,000 options to buy
@ $4.55, valued at
$63.7k
|
|
04/26/2021 |
4/A
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 140,000 options to buy
@ $5.89, valued at
$824.6k
|
|
04/26/2021 |
4/A
| Musil Clinton (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.
Txns:
| Granted 54,000 options to buy
@ $5.89, valued at
$318.1k
|
|
|